Prime-2-CoV_Beta clinical trials

A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

This study is testing a new COVID-19 vaccine booster called Prime-2-CoV_Beta in healthy adults aged 18-55. Researchers want to see if it's safe and how well it boosts your immune system to fight the virus. It's an early-stage study to work out the best dose.